- bulk
Supplier Type
- Manufacturer
- Reagent
- Trader
- contract manufacturer
- custom synthesis
Supplier Region
- Hyderabad(36)
- Gujarat(22)
- Ahmedabad(15)
- Maharashtra(23)
- Vadodara(5)
- Mumbai(37)
- Madhya Pradesh(1)
- Delhi(10)
- Uttar Pradesh(2)
- Tamil Nadu(2)
- Karnataka(6)
- Beijing(1)
- Andhra Pradesh(2)
- Bangalore(3)
- Telangana(4)
- Pune(3)
- Haryana(6)
- New Delhi(4)
- Himachal Pradesh(1)
- Kolkata(2)
- Nagpur(1)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- NLT 99%
- NLT 95%
- NLT 90%
- more than 95%
- more than 90%
- Min. 99.0%
- Min. 80%
- Mesalazine EP Impurity H
- Greater than 99%
- Dipropargyl r- amino indane
- Acetylsalicylic Acid EP Impurity C
- 99.999% (5N)
- 99.99%
- 99.94%
- 99.93%
- 99.90%
- 99.9%
- 99.9 %
- 99.86%
- 99.85%
- 99.80%
- 99.77%
- 99.68%
- 99.6
- 99.55%
- 99.50%
- >99.5%
- 99.5 %
- 99.34%
- 99.30%
- 99.00%
- 99% Pure
- 99% HPLC
- >99%
- 99%
- 99 %
- 99
- 98+
- 98.91%
- 98.70%
- 98.68%
- 98.66%
- 98.58%
- 98.57%
- 98.50%
- 98.20%
- 98.00%
- >98%
- 98%
- 98
- 97-99%
- 97.57%
- 97.33%
- 97.00%
- >97%
- 97%
- 97 to 98
- 97 %
- 96.64%
- 96.40%
- 96.25%
- 96.13%
- 96%
- 95.62%
- 95.00%
- >95%
- 95%
- 95 %
- 94.25%
- 94%
- 93.21%
- 92.60%
- >92%
- >90%
- 90%
- 90 % Above
- 86.74%
- 80% min
- 65%
- 600
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 100%
- 1.0M
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 1mg
- 50
- 25
- 200
- 100
- 0MG TO GRAM
- 100mg
- 11Between 1 gm to 1 MT (As per availability)
- 25mg
- 50mg
- 250mg
- 500mg
- 1g
- 1gm
- 5g
- 10g
- 25g
- 50g
- 100ml
- 100g
- 100gm
- 500ml
- 500g
- 1kg
- 1L
- 5kg
- 10kg
- 25kg
- 50kg
- 100kg
- 500kg
- 1MT
- 1and gm
- 95NLT %
- 250kgs
- 250250 mg.
-
Brivaracetam (alfaR, 4S)-Isomer
357336-99-3
-
(3'R)-Ezetimibe
163380-16-3
-
(R)-9-((triisopropylsilyl)oxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-onehydrochloride
1190363-45-1
-
(S)-2-(2,6,7,8-tetrahydro-1H-indeno[5,4-b]furan-8-yl)acetic acid
1092507-03-3
-
(5'R,8'S,10'R,13'S,14'S,17'S)-13'-METHYL-17'-(PROP-1- YN-1-YL)-1',2',7',8',12',13',14',15',16',17'-DECAHYDRO- 4'H,6'H-SPIRO[[1,3]DIOXOLANE-2,3'- [5,10]EPOXYCYCLOPENTA[A]PHENANTHREN]-17'-OL
-
(+)-(3AR,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-[(1E,3R)-3-HYDROXY-4-(3-TRIFLUOROMETHYL)PHENOXY-1-BUTENYL]-2H-CYCLOPENTA[B]FURAN-2-ONE
53872-60-9
-
(R)-9-[(1,4'-Bipiperidine)-1'-carbonyloxy]-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline hydrochloride, trihydrate
3079028-50-2
-
2H-Cyclopenta[b]furan-2-one, hexahydro-5-[(tetrahydro-2H-pyran-2-yl)oxy]-4-[(1E,3R)-3-[(tetrahydro-2H-pyran-2-yl)oxy]-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-, (3aR,4R,5R,6aS)-
208180-17-0
-
2H-Cyclopenta[b]furan-2-ol, hexahydro-5-[(tetrahydro-2H-pyran-2-yl)oxy]-4-[(1E,3R)-3-[(tetrahydro-2H-pyran-2-yl)oxy]-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-, (3aR,4R,5R,6aS)-
208252-64-6
-
Sulfameter-d4, 1 mg
(R)-(-)-3-Carbamoymethyl-5-methylhexanoic acid 181289-33-8
(R)-(-)-3-Carbamoymethyl-5-methylhexanoic acid 181289-33-8
R-(-)-5-(2-Aminopropyl)-2-methoxy benzenesulfonamide 112101-81-2
5,6-Dihydro-4-hydroxy-6-methyl-4H-thieno-[2,3-b]thiopyran-2-sulfonamide-7,7-dioxide 120279-26-7
(R)-Phenylephrine 59-42-7
Rhodamine B base 509-34-2
99% Lamivudine EP Impurity C 69-72-7
